Literature DB >> 7524987

The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars.

U Bertheim1, S Hellström.   

Abstract

A hyaluronan-binding protein (HABP) was used to locate the distribution of HA in normal skin and in various types of scar tissue: mature scar tissue, hypertrophic scar tissue and keloids. The study was intended to establish whether or not a deviant HA distribution could explain the different clinical features of these scar tissues. The distribution of HA was found to differ between the various scar tissues. In normal skin an intense HA-staining was observed in the papillary dermis. In mature scar tissue the distribution of HA resembled that of normal uninjured tissue, but the layer of HA was thinner. In hypertrophic scar tissue, HA occurred mainly as a narrow strip in the papillary dermis. Keloid tissue showed the least HA-staining of the papillary layer and resembled that of the bulging reticular dermis. In contrast, the thickened granular and spinous layer of the keloid epidermis exhibited an intense HA-staining. We suggest that the altered distribution and amount of HA in these different scar tissues may contribute to their different clinical characteristics. This histochemical technique for the demonstration of HA in scar tissue could be of use in clinical work to decide on therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524987     DOI: 10.1016/0007-1226(94)90031-0

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  11 in total

1.  Surface treatment of flexor tendon autografts with carbodiimide-derivatized hyaluronic Acid. An in vivo canine model.

Authors:  Chunfeng Zhao; Yu-Long Sun; Peter C Amadio; Toshikazu Tanaka; Anke M Ettema; Kai-Nan An
Journal:  J Bone Joint Surg Am       Date:  2006-10       Impact factor: 5.284

2.  [Hyperplastic scars and keloids. Part I: basics and prevention].

Authors:  A Baisch; F Riedel
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

3.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

4.  Characterization of hyaluronan and TSG-6 in skin scarring: differential distribution in keloid scars, normal scars and unscarred skin.

Authors:  K T Tan; D A McGrouther; A J Day; C M Milner; A Bayat
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03       Impact factor: 6.166

5.  Anti-aging and filling efficacy of six types hyaluronic acid based dermo-cosmetic treatment: double blind, randomized clinical trial of efficacy and safety.

Authors:  Vincenzo Nobile; Daniela Buonocore; Angela Michelotti; Fulvio Marzatico
Journal:  J Cosmet Dermatol       Date:  2014-12       Impact factor: 2.696

6.  Effect of Wubeizi ointment aqueous solution on the expression of type I and III procollagen genes in keloid fibroblasts.

Authors:  Xiao-Xiang Zhai; Ji-Cun Ding; Zhi-Ming Tang; Jing-Guo Li; Xiang-Hui Chen; Cui-Xia Zhang
Journal:  Exp Ther Med       Date:  2016-12-30       Impact factor: 2.447

Review 7.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

Review 8.  Keloidal pathophysiology: Current notions.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Scars Burn Heal       Date:  2021-05-31

9.  Hyaluronic acid: A key molecule in skin aging.

Authors:  Eleni Papakonstantinou; Michael Roth; George Karakiulakis
Journal:  Dermatoendocrinol       Date:  2012-07-01

10.  Keloids and hypertrophic scars: update and future directions.

Authors:  Chenyu Huang; George F Murphy; Satoshi Akaishi; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.